Evidence map›Paper›PMID 40097442›Full record

ArticleNature communications2025

SSUP-72/PINN-1 coordinates RNA-polymerase II 3' pausing and developmental gene expression in C. elegans.

François-Xavier Stubbe, Pauline Ponsard, Florian A Steiner, Damien Hermand

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Systematic optimization ofBiochemistry and biophysics reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

François-Xavier StubbeURPHYM-GEMO, The University of Namur, Namur, Belgium.ORCID http://orcid.org/0000-0002-8550-9046
Pauline PonsardURPHYM-GEMO, The University of Namur, Namur, Belgium.
Florian A SteinerDepartment of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-0514-5060
Damien HermandURPHYM-GEMO, The University of Namur, Namur, Belgium. Damien.Hermand@crick.ac.uk.ORCID http://orcid.org/0000-0002-1029-5848

Funding

Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) FNRS J.0066.16Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) FNRS T.0112.21Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) U.N032.22
6 · The paper itself

Abstract

During exit from Caenorhabditis elegans (C. elegans) L1 developmental arrest, a network of growth- and developmental genes is activated, many of which are organized into operons where transcriptional termination is uncoupled from mRNA 3'-end processing. CDK-12-mediated Pol II CTD S2 phosphorylation enhances SL2 trans-splicing at downstream operonic genes, preventing premature termination and ensuring proper gene expression for developmental progression. Using a genetic screen, we identified the SSUP-72/PINN-1 module as a suppressor of defects induced by CDK-12 inhibition. Loss of SSUP-72/PINN-1 bypasses the requirement for CDK-12 in post-embryonic development. Genome-wide analyses reveal that SSUP-72, a CTD S5P phosphatase, affects Pol II 3' pausing and regulates intra-operon termination. Our findings establish SSUP-72/PINN-1 as a key regulator of Pol II dynamics, coordinating operonic gene expression and growth during C. elegans post-embryonic development.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsGene Expression Regulation, DevelopmentalPhosphoprotein PhosphatasesRNA Polymerase IIAnimalsOperonPhosphorylationCaenorhabditis elegans ProteinsPhosphoprotein PhosphatasesRNA Polymerase II

Identifiers

PMID40097442
PMCPMC11914089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.